AlegsaOnline.com

Prenatal diagnosis: methods, applications, risks, and ethical considerations

Comprehensive overview of prenatal diagnosis: screening and diagnostic methods, conditions evaluated, clinical uses, risks and timing, counseling, and ethical and legal concerns.

Author: Leandro Alegsa Creation date: November 13, 2022 Last updated: June 15, 2026

en.wikipedia.org · CC BY-SA 4.0

Prenatal diagnosis refers to medical tests performed during pregnancy to assess the health and development of the embryo or fetus. These procedures are offered to pregnant women and others carrying a pregnancy to identify structural anomalies, chromosomal changes and certain inherited conditions affecting the child. The information produced by prenatal testing may guide medical management, birth planning, decisions about pregnancy continuation, or preparation for a baby with special needs.

Methods: non-invasive and invasive

Broadly, prenatal testing falls into two categories. Non-invasive options evaluate maternal blood or use imaging and pose no direct risk to the pregnancy. Common non-invasive approaches include sonographic examination with ultrasound and laboratory screening of maternal serum; newer techniques analyse cell-free fetal DNA in maternal blood. Invasive diagnostic procedures obtain fetal or placental material and carry a small risk of miscarriage. Examples are amniocentesis and chorionic villus sampling, which sample amniotic or placental tissue and fluid (placental sampling or amniotic fluid testing). Timing varies: screening tests are often done in the first or second trimester, while definitive diagnostic tests are typically performed later.

What conditions are tested

Tests target a range of problems, from chromosomal abnormalities to single-gene disorders and structural defects. Screening and diagnostic programs commonly address:

Down syndrome and other aneuploidies
Neural tube defects such as spina bifida
Cleft lip and palate and other structural malformations
Tay–Sachs disease, cystic fibrosis, and other inherited metabolic or respiratory conditions
Sickle-cell disease and thalassaemia
Fragile X syndrome and other single-gene disorders

Clinical uses and outcomes

Results from prenatal diagnosis can be used to refine prenatal care, arrange specialist delivery facilities, initiate in utero or early postnatal treatment when available, or help families prepare emotionally and practically for a child with special needs. In some settings, findings influence the consideration of pregnancy termination (abortion), though legal and cultural responses vary. Screening may also detect non-pathological traits; for example, identification of fetal sex can lead to sex-selective practices in certain regions when a fetus is identified as female.

Risks, counseling, and decision-making

Invasive tests carry procedural risks and all testing has psychological and ethical implications. Pre-test counseling is recommended so people understand the scope and limits of results, possible false positives or negatives, and follow-up options. Genetic counseling helps interpret findings in the context of family history and reproductive choices. Where available, multidisciplinary teams assist with prognosis, treatment options and coordination of care after birth.

Advances in prenatal technology have raised complex questions, including concerns about reproductive autonomy, privacy, disability rights, and social pressure toward particular reproductive outcomes. Debates over so-called designer babies reflect worries about selecting non-medical traits and widening inequalities. Policymakers, clinicians and ethicists also examine the ethical issues of access, consent and the potential for discrimination. The balance between offering useful clinical information and protecting individual and societal values continues to shape practice and regulation worldwide.

For people considering prenatal testing, authoritative counseling and accurate, balanced information are essential. Further reading and local guidance are available through clinical services and professional organizations (see resources for pregnant people, fetal medicine, birth defect registries, genetic disorder references, ultrasound guidance, diagnostic sampling, Down syndrome information, Tay–Sachs resources, sickle-cell resources, thalassaemia support, cystic fibrosis guidance, Fragile X information, termination law, sex selection discussions, emerging reproductive technologies, ethical analyses).

Sonographic image of a fetus at 12 weeks of gestation

History

Investigations in reproductive medicine

Prefertilisation diagnostics:
Examination of the egg before fertilisation

Preimplantation genetic diagnosis:
Examination of the embryo before implantation into the uterus.

Prenatal diagnostics:
Examination of the fetus before birth

The first amniocenteses for prenatal diagnostics were performed in 1930 by Thomas Menees and others. The foundation of modern prenatal diagnostics was laid by the British obstetrician Ian Donald in 1958 with the first sonographic imaging of an unborn child. The technical advancement of ultrasound equipment enabled a high resolution of detail and thus the detection of structural malformations of fetal organs with a high diagnostic certainty. Thus, the diagnosis of abdominal wall hernias, diaphragmatic hernias, displacements of the heart axis, malformation of organs such as the lungs or kidneys, cystic kidneys, malformations of the extremities, obstructions in the gastrointestinal tract, etc. became possible.

Non-invasive ultrasound technology was extended by the development of invasive techniques. Thus, in 1966, Steele and Breg demonstrated the possibility of sampling and chromosomal examination of fetal cells contained in the amniotic fluid (amniocentesis) during the second trimester of pregnancy. This was followed in the early 1980s by the publication of chorionic villus sampling. In this procedure, cells are taken from the villi of the egg skin (chorion) during the first trimester of pregnancy, which later forms the placenta. These cells are cultured and subjected to genetic analysis. Later, with early amniocentesis, puncture of fetal vessels and fetal organs, and collection of blood from the umbilical cord, further measures for the collection of fetal cells followed.

More recently (as of 2006), fetal MRI has also become increasingly available as a non-invasive diagnostic method. The basis for referral is often a suspected sonographic diagnosis. The clarification of rare syndromes is possible by means of MRI with a high diagnostic certainty.

Up to now, invasive examination procedures have been burdened with different risks that depend on various factors, e.g. that of a miscarriage. As a result, in addition to the basic need of prospective parents worldwide to have a physically and cognitively healthy, non-disabled child, and the desire to know about the child's state of health, the trade-off between the risks of the examination and the likelihood of a particular disability usually plays an important role in the decision to use an invasive examination.

However, this can have far-reaching social and legal consequences: Those doctors who advise against an invasive examination such as amniocentesis or chorionic villus sampling sometimes find themselves exposed to claims for damages in the event of the birth of a child with a disability detectable by the examination. This is one of the reasons why a nationwide offer of prenatal examinations with a high diagnostic certainty has been established in Germany in the meantime, which sometimes gives the impression of "avoidability" of children with disabilities due to the meanwhile quite high degree of awareness of different examination procedures.

As risk-free, albeit non-diagnostic examinations, addiction tests such as the double test, triple test and nuchal translucency measurement as part of first trimester screening are currently popular. They provide indications of a possible chromosomal abnormality or of certain physical malformations, e.g. in the area of the spinal canal, the abdominal wall and the kidneys. The extent to which these procedures should be used across the board in Germany as part of maternity screening is still the subject of controversial ethical and health policy discussions.

Since the early 1990s, intensive research has been conducted worldwide into non-invasive examination methods (NIPT), in which the genetic material of the fetus can be extracted from cells in the blood of the pregnant woman and examined for genetic abnormalities without risk, in order to avoid the use of invasive procedures with a risk of miscarriage for chromosome extraction. According to Hepp, this procedure was in clinical trials in 1999.

According to researchers at Stanford University in California, they succeeded in 2008 in enriching isolated fetal cells present in maternal blood, subjecting them to DNA analysis and thus making many invasive examinations carried out for this purpose superfluous. The NIPT procedure was successful in detecting 12 different chromosomal disorders.

Application Risks

Non-invasive tests

→ Main article: Non-invasive prenatal test

In the case of non-invasive examinations (= examinations that do not penetrate the pregnant woman's body), such as an examination of maternal blood (NIPT) and also in the case of an ultrasound examination such as nuchal translucency measurement, there are no risks for the unborn child and its mother according to the current state of knowledge (2014).

Invasive examinations

In various medical textbooks with research status 2000, 2005 and 2007, approx. 1 % intervention-related risk of abortion is assumed for amniocentesis (amniocentesis) and for chorionic villus sampling.

According to recent studies, invasive (invading the pregnant woman's body) diagnostic procedures such as amniocentesis, chorionic villus sampling, or umbilical cord puncture pose little risk to the fetus.

For example, in 2006, a study examined 35,003 unselected pregnant patients from the normal population. It was found that the risk of miscarriage in patients who did not have amniocentesis was 0.94%, whereas the risk of miscarriage in the women in the study group increased to only 1.0%. Amniocentesis showed no statistically significant effect on the risk of miscarriage in this study.

Another study from 2006, which evaluated 9,886 chorionic villus sampling and 39,893 amniocentesis, shows that there is no significant difference in risk between the two screening methods.

Psychological stress

Until a conclusive test result is available, there is sometimes a restricted mother-child relationship due to the socially and personally at least latently assessed basis as "pregnancy on trial". In some cases, an emotionally strong bond is only allowed when the results are unremarkable, which means that the option of terminating the pregnancy in the case of abnormal results is also kept as emotionally open as possible. Sometimes the time up to this point is psychologically difficult for the pregnant woman; "most feelings of guilt arise from the feeling of having put the child up for disposal", since the health of the fetus is regarded as the decisive criterion for its acceptance or rejection. On the other hand, an unremarkable finding helps to reassure parents. Expectant parents are advised to seek counselling before making use of prenatal diagnostics. Especially in the case of family history, it is advisable to visit a genetic counselling centre.

Grafische Darstellung deutscher Mutterschafts-Richtlinien